Cost‐effectiveness of a transition from volatile anaesthesia to total intravenous anaesthesia to reduce carbon footprint: an economic modelling study
Main finding · Carbon footprint (kg carbon dioxide equivalent)Result — go to the resultIncremental cost-effectiveness ratio £416 per tonne carbon dioxide equivalentAuthors' conclusion
Using our model parameters and the different carbon dioxide emissions and similar cost, transitioning from desflurane anaesthesia to total intravenous anaesthesia is cost-effective.
Study context
- Population
- Modelled general anaesthetic for a 40-year-old, 78-kg patient
- Comparison
- Propofol-remifentanil TIVA vs desflurane or sevoflurane
- Outcome
- Cost per kg carbon dioxide equivalent saved by transition to TIVA, benchmarked against UK emission trading scheme carbon permit price of £41.84 per tonne carbon dioxide equivalent
Methodological detailscost-effectiveness analysis
- Cost-effectiveness analysis
Main finding
Carbon footprint (kg carbon dioxide equivalent)
Incremental cost-effectiveness ratio
£416 per tonne carbon dioxide equivalent
By group
As reported in the abstract
Further findings
| Outcome | Sevoflurane | Desflurane |
|---|---|---|
| Cost per anaesthetic | £9.76 | £18.94 |
- Cost per anaesthetic: TIVA with processed EEG £13.03
- Cost per anaesthetic: TIVA without processed EEG £5.31
Cost per anaesthetic
- TIVA (with and without processed EEG) cheaper than desflurane
Original publication
Cost‐effectiveness of a transition from volatile anaesthesia to total intravenous anaesthesia to reduce carbon footprint: an economic modelling study. Anaesthesia. Published 14 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →